FF

FutureFuel Corp. 10-Q Summary: Q3 2025

Business Context and Reporting Period

FutureFuel Corp. (NYSE: FF) is an accelerated filer and smaller reporting company engaged in the manufacturing of chemicals and biofuels. This report covers the quarterly period ended September 30, 2025. The company operates two reportable segments: Chemicals (custom and performance chemicals) and Biofuels (biodiesel and related products). As of November 10, 2025, there were 43,803,243 shares of common stock outstanding.

Key Financial Metrics

Note: All figures in millions unless otherwise noted. The company has a $75 million revolving credit facility with no borrowings outstanding as of September 30, 2025.

Material Changes vs. Prior Period

• Revenue Decline: Revenue decreased 56% in Q3 and 58% YTD compared to the prior year. The decline was driven primarily by the Biofuels segment, which saw a 79% drop in Q3 revenue due to the temporary idling of the biodiesel production line.
• Profitability Reversal: The company swung from a net income of $12.7 million in the first nine months of 2024 to a net loss of $37.4 million in the same period of 2025. Gross margin turned negative in both segments for the current period.
• Segment Performance:
  • Chemicals: Revenue fell 13% in Q3 and 25% YTD due to lower volumes in polymer coatings and energy markets, as well as reduced glycerin sales linked to the biodiesel plant shutdown.
  • Biofuels: Revenue fell 79% in Q3 and 73% YTD. Management attributed this to market uncertainty regarding the Clean Fuel Production Credit (CFPC) and an extended plant turnaround.
• Inventory Liquidation: A LIFO inventory liquidation of $5.1 million occurred in the first nine months of 2025, partially offsetting the gross loss. Inventory levels dropped significantly from $20.6 million at year-end 2024 to $6.1 million at Q3 2025.

Guidance, Outlook, and Risks

• Operational Status: The biodiesel production line was idled in Q3 2025 due to weak market conditions. Management retained key employees to facilitate a restart when conditions improve. A plant turnaround was also conducted to improve reliability.
• Regulatory Environment:
  • CFPC: The Budget Reconciliation Act of 2025 extended the Clean Fuel Production Credit through 2029. The company recognized $2.5 million in CFPC benefits for the nine months ended September 30, 2025.
  • EPA RFS Proposal: The EPA proposed rules for 2026-2027 that could increase biomass-based diesel volume requirements but reduce RINs for imported fuels. The final rule is pending and could materially affect operations.
• Liquidity: Despite the net loss, the company maintains a strong liquidity position with $85.6 million in cash and a $75 million undrawn credit facility. Management believes existing resources are sufficient to fund operations and capital requirements for the foreseeable future.
• Dividends: The company paid regular quarterly dividends of $0.06 per share in 2025. A special dividend of $2.50 per share was paid in Q1 2024, which significantly impacted financing cash flows in the prior year.
• Risks: Key risks include commodity price volatility (feedstocks like yellow grease and cottonseed oil), reliance on major customers for biofuel sales, and regulatory changes affecting renewable fuel credits.

Investor Verification Checklist

• Production Restart Timeline: Verify management's specific timeline and conditions for restarting the idled biodiesel production line.
• CFPC Utilization: Confirm the company's ability to fully utilize the extended Clean Fuel Production Credit given current production volumes.
• Customer Concentration: Review the dependency on the three major biofuel customers identified in the filing and the terms of their purchase orders.
• Inventory Valuation: Assess the impact of the LIFO liquidation on future cost of goods sold as inventory levels rebuild.
• Capital Allocation: Monitor the balance between continued capital expenditures ($14.8M YTD) and dividend payments amidst operating losses.